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Abstract
BACKGROUND: Recently, portal venous pressure (PVP) exhibited high sensitivity and specificity in anticipating 
death in cirrhotic cases submitted to emergency operations. 
AIM: The current prospective work aimed to evaluate the utility of PVP in predicting 1st month post-operative death 
in Child’s A cirrhotic cases who underwent elective operations.
METHODS: One-hundred and twenty cirrhotic cases that were planned to undergo elective surgery were enrolled 
in the current prospective work. The intraoperative (I.O) PVP and central venous pressure (CVP) were measured. 
The statistical analysis was performed using the SPSS version 22.0. The receiver operative curve was plotted 
to measure the predictive value of PVP. Multivariate analysis was done using logistic regression method for the 
significant variables impacting mortality on univariate analysis.
RESULTS: Twenty-nine patients died in the current work. Patients who survived had statistically considerably lower PVP 
than patients who died (8.2 ± 1.5 vs. 12.5 ± 1.6 mmHg, respectively, p < 0.001). Similarly, patients who died had significantly 
higher I.O CVP (p < 0.001), body mass index (p < 0.001), and were more likely to have model for end-stage liver disease 
score between 9 and 16 (p = 0.003). At a cutoff value ≥10.5 mmHg, the PVP had a sensitivity of 82.8% and specificity of 
93.4% for the prediction of mortality. The logistic regression analysis showed that only PVP (odds ratio [OR] =3.1, 95% 
confidence interval [CI] 1.25–7.5) and CVP (OR = 2.8, 95% CI 1.2–6.5) were the only independent predictors of mortality.
CONCLUSION: PVP is a significant predictor of death in Child’s A cirrhotic cases submitted to elective operations.
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Introduction
Liver cirrhosis is a major public health burden that 
is characterized by progressive, usually irreversible, loss 
of normal hepatic architecture, and functions [1]. According 
to recent epidemiological figures, the prevalence of 
histological cirrhosis ranges from 4.5% to 9.5% of the 
global adults population and is responsible for more than 1 
million deaths in 2010 [2], [3]. The condition can occur as 
the end stage of chronic liver diseases, mainly alcoholic 
liver disease and viral hepatitis, and frequently remain 
asymptomatic until the development of complications [4]. 
Cirrhosis is a leading cause of morbidity worldwide with 
increased risks of a wide range of complications. Patients 
with cirrhosis can develop hepatic encephalopathy, 
ascites, bleeding varices, spontaneous bacterial peritonitis, 
and hepatocellular carcinoma as a result of severe liver 
cirrhosis [5]. Cirrhosis is one of the main contributors to 
the global mortality rate. Despite the major advances in the 
management of many causes of cirrhosis, it is expected 
that cirrhosis-related mortality will be tripled by 2030 [6].
On the other hand, anesthesia and surgery 
in cirrhotic patients are associated with a significant 
increase in the risks of morbidity and mortality. The 
previous reports have shown that the rates of serious 
complications and death are significantly higher in 
cirrhotic patients undergoing surgery than the normal 
population [7]. The mortality rates in patients with 
well-compensated or occult cirrhosis, who underwent 
surgical procedures, were reported to be as high as 
25% [8]. Therefore, proper pre-operative assessment is 
critical in cirrhotic patients to improve the post-operative 
outcomes [9]. Over the past few decades, various 
biomarkers and predictive models were proposed for 
the prediction of death in cirrhotic cases submitted to 
elective and urgent surgeries. Child-Turcotte-Pugh 
classification, model for end-stage liver disease 
(MELD) score, prothrombin time, and other risk factors 
exhibited a significant correlation with post-operative 
death in patients with end-stage liver disease [10], [11].
Elevated portal pressure is one of the main 
features of advanced liver cirrhosis. The condition is 
defined as an elevation in portal venous pressure (PVP) 
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above 12 mmHg, or hepatic venous pressure gradient 
above 5 mmHg, as a result of increased intrahepatic 
vascular resistance [12]. Portal hypertension is the leading 
pathophysiological mechanism for many cirrhotic-related 
complications with increased mortality and morbidity. 
The previous reports showed that the elevation in 
PVP could significantly predict the development and 
severity of esophageal varices [13], post-operative liver 
function before liver surgery [14], and survival [15]. More 
recently, PVP exhibited high sensitivity and specificity in 
anticipating death in cases with end-stage liver disease, 
who underwent emergency surgery [16]. However, the 
predictive role of PVP in cirrhotic cases scheduled for 
elective procedures is still questionable.
Thus, we performed this prospective work to 
evaluate the utility of PVP in portending early post-
operative death in Child’s A cirrhotic cases submitted to 
elective surgery.
Materials and Methods
The manuscript of the present study was 
conducted guided by the criteria of the strengthening 
reporting of observational studies in epidemiology [17]. 
We emphasize that this work was consistent with the 
Declaration of Helsinki and applicable local regulatory 
rules.
Work design and patients
This prospective cohort work was performed 
from November 2016 to November 2018 at Cairo and 
Ain Shams University Hospitals. Adult cirrhotic patients 
(18–65 years old) who were planned to undergo elective 
procedures were enrolled. Cirrhosis was confirmed by 
a constellation of clinical, laboratory, and radiological 
diagnoses.
Patients with Child B or C liver cirrhosis, 
hepatic malignancy, pre-operative portal or mesenteric 
vein occlusion, or acute surgical emergency were 
not included in the study. Written informed approval 
was taken from every participant before the study’s 
enrollment, and the study protocol acquired the 
confirmation of the responsible ethics and research 
board.
Body mass index (BMI) was determined as 
follows: The body weight divided by the square of the 
body height (kg/m2) [18].
Diabetes mellitus confirmation was done 
according to the American Diabetes Association 
guidelines (glycated hemoglobin “HbA1C” more than 
6.5% or fasting blood glucose more than 126 mg/dL or 2 h 
plasma glucose more than 200 mg/dL after oral glucose 
tolerance test) [19]. Hypertension was confirmed if 
blood pressure was more than 140/90 mmHg on three 
or more separate occasions [20].
Study’s procedures
After detailed history taking and thorough physical 
examination, all included patients underwent routine pre-
operative laboratory work-up comprising complete blood 
count, bleeding profile, hepatic, and renal functions.
Intraoperatively, the rate of infusion of 
crystalloid during the procedure was modified depending 
on the hemodynamic preload (with central venous line 
inserted into the right internal jugular vein) and urine 
output. Packed red blood cells were given to keep 
the hematocrit, between 25% and 30%. Fresh frozen 
plasma, cryoprecipitate, and platelets were infused to 
treat intraoperative (I.O) coagulopathy.
In addition, one measurement of the PVP was 
acquired at the start of the operation. The PVP was 
assessed intraoperatively through an 18-gauge catheter, 
which was placed into one of the large jejunal, ileal 
mesenteric tributaries, or the main inferior mesenteric 
vein. The other side was connected through an extension-
arterial line to a pressure transducer. If attainable, both the 
main inferior mesenteric vein and one large mesenteric 
tributary pressure were measured, and the mean value was 
considered. The normal range for directly measured PVP 
values was considered to be 5–10 mmHg [21]. A figure of 
eight suture was performed in case of continuous oozing 
from the puncture site despite a proper compression.
Study’s objectives
The primary objective in this work was the 
sensitivity and specificity of the PVP for the prediction 
of post-operative 1st month mortality. The secondary 
objectives were the association between other variables 
(age, gender, comorbidities, operation type, and MELD) 
and mortality.
Statistical analysis
Data registry and statistical analysis were 
carried out using the SPSS version 22.0. Frequency 
tables with percentages were used for categorical 
data. Mean and standard deviation (SD) or median 
(range) were used for the description of numerical data 
according to the normality of the data. The normality 
of the data was evaluated using Shapiro–Wilk Test. 
Tests of significance (Chi-square, Student’s t-test, or 
Mann–Whitney’s U-test) were used depending on the 
normality of the data. The receiver operative curve 
(ROC) was plotted to measure the predictive value 
of PVP. Multivariate analysis was performed using 
logistic regression method for the significant variables 
impacting mortality on univariate analysis. p < 0.05 was 
considered statistically significant.
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Results
The current report enrolled 120 cirrhotic 
patients who underwent elective surgery. The mean age 
of the included cases was 52.12 ± 6.1 years, and most 
cases were male (87.5%). The performed procedures 
were open splenectomy (37.5%), open cholecystectomy 
(33.3%), and colectomy (29.2%). The most common 
cause of cirrhosis was hepatitis C (75%) and B (17.2%). 
Most of the patients (84.2%) had a MELD score between 
9 and 16. The pre-operative laboratory investigations 
showed unremarkable values. Table 1 demonstrates the 
demographic and clinical data of the study groups.
Table 1: The demographic and pre-operative data of the study 
groups
Variables Patients (n=120)
Male, no. (%) 105 (87.5)
Age (years), mean ± SD 52.12 ± 6.1
BMI (kg/m2), mean ± SD 27.2 ± 3.1
Diabetes, no. (%) 79 (65.8)
Hypertension, no. (%) 95 (79.2)
Cause of cirrhosis, no. (%)
HCV 90 (75)
HBV 17 (14.2)
Cryptogenic 8 (6.7)
Others 5 (4.2)
Operation, no. (%)
Open cholecystectomy 40 (33.3)
Open splenectomy 45 (37.5)
Colectomy 35 (29.2)
MELD, no. (%)
≤8 19 (15.8)
9–16 101 (84.2)
Hemoglobin (g/dL), mean ± SD 10.8 ± 1.2
TLC×1000 (cell/mm2), mean ± SD 6.8 ± 1.9
Platelet, mean ± SD 219.9 ± 80.9
CRP (mg/dL), median (range) 6 (6–24)
INR, mean ± SD 1.2 ± 0.1
Bilirubin (mg/dL), mean ± SD 1.3 ± 0.3
AST (IU/L), median (range) 40.5 (16–78)
ALT (IU/L), median (range) 42 (15–56)
ALP (IU/L), median (range) 114 (67–298)
GGT(IU/L), median (range) 119.5 (55–311)
Bilirubin (g/dL), mean ± SD 3.6 ± 0.3
BMI: Body mass index, TLC: Total leukocytic index, CRP: C-reactive protein, AST: Aspartate aminotransferase, 
ALT: Alanine aminotransferase, ALP: Alkaline phosphatase, GGT: Gamma-glutamyl transferase.
Twenty-nine patients (24.2%) died in the 
present study. Causes of mortality included sepsis 
in 13 (10.8%) patients, hepatic decompensation in 
7 (5.9%) patients, myocardial infarction in 6 (5%) 
patients, and pulmonary embolism in 3 (2.5%) patients.
Figure 1: The distribution of portal venous pressure according to 
mortality
Patients who survived had a statistically 
significant lower PVP than patients who died 
(8.2 ± 1.5 vs. 12.5 ± 1.6 mmHg, respectively, p < 
0.001; Figure 1). Similarly, patients who died had 
significantly higher IO central venous pressure (CVP) 
(p < 0.001), BMI (p < 0.001), and were more likely 
to have MELD score between 9 and 16 (p = 0.003). 
In contrast, there were no statistically significant 
associations between mortality and other clinical 
variables (Table 2).
Table 2: The association between mortality rate and study’s 
variables
Variables Non-survivors (n=29) Survivors (n=91) p-value
Male, no. (%) 26 (89.7) 79 (86.8) 0.485
Age (years), mean ± SD 52.3 ± 5.3 51.9 ± 6.4 0.68
BMI (kg/m2), mean ± SD 29.3 ± 2.1 26.5 ± 3.1 <0.001**
Diabetes, no. (%) 19(65.5) 60 (65.9) 0.56
Hypertension, no. (%) 25 (86.2) 70 (76.9) 0.21
Operation, no. (%)
Open splenectomy 10 (34.5) 35 (38.4) 0.43
Colectomy 9 (31) 26 (28.6)
Open cholecystectomy 10 (34.5) 30 (33)
MELD, no. (%)
≤8 0 19 (20.9) 0.003*
9–16 29 (100) 72 (79.1)
PVP (mmHg), mean 
± SD
12.5 ± 1.6 8.2 ± 1.5 <0.001**
CVP (mmHg), mean 
± SD
12.6 ± 1.9 8.3 ± 1.7 <0.001**
*p<0.05 significant, **p<0.001 highly significant. BMI: Body mass index, MELD: Model for end-stage liver 
disease, PVP: Portal venous pressure, CVP: Central venous pressure.
The ROC showed that the PVP was a significant 
discriminator of the occurrence of death with an area 
under the curve of 0.971 (p = 0.001; Figure 2). At a
Figure 2: The receiver operating characteristic of the predictive value 
of portal venous pressure
cutoff value of ≥10.5 mmHg, the PVP had a sensitivity 
of 82.8% and specificity of 93.4% for the prediction 
of mortality. The logistic regression analysis showed 
that only PVP (odds ratio [OR] =3.1, 95% confidence 
interval [CI] 1.25–7.5) and CVP (OR = 2.8, 95% CI 
1.2–6.5) were the only independent predictors of 
death.
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Discussion
Recently, PVP was reported to be an 
independent risk factor of death in cirrhotic cases 
undergoing emergency surgery [16]; however, its 
predictive utility in the setting of elective surgical 
interventions in patients with early cirrhosis is still 
questionable.
In the present study, we found that PVP 
yielded an acceptable diagnostic accuracy for the 
prediction of mortality in Child’s A cirrhotic patients, a 
PVP level ≥10.5 mmHg exhibited a sensitivity of 82.8% 
and specificity of 93.4% for the prediction of mortality. 
Besides, this report showed that BMI and CVP were 
associated with death with high statistical significance. 
The logistic regression analysis showed that PVP and 
CVP were independent predictors of mortality.
The currently published body of evidence 
shows that different surgical procedures are linked to a 
high risk of adverse outcomes in cirrhotic cases, mainly 
as a result of hyperdynamic circulation and hepatic 
hypoxemia [22]. The risk of post-operative mortality was 
reported to be significantly correlated with the degree 
of liver diseases; therefore, higher PVP can potentially 
reflect the increased risk of mortality as the progression 
of fibrosis parallels the increase in portal pressure 
[23]. The present study showed that PVP was an 
independent risk factor of early death. Recently, Salman 
et al. [16] found that portal hypertension is a significant 
predictor of the 30-day post-operative death in Child’s 
Class A-C cirrhotic cases submitted to emergency 
procedures, the PVP yielded high sensitivity (83.6%) 
and specificity (92%). Similarly, Nguyen et al. [24] found 
that the mortality rate was significantly higher in cirrhotic 
cases with elevated portal pressure undergoing elective 
colorectal surgery, in comparison with cases with normal 
PVP. Given this significant impact of high PVP on the 
outcomes of surgery in cirrhotic patients, the previous 
reports suggested that portal decompression by 
transjugular intrahepatic portosystemic shunt (TIPS) can 
potentially improve the survival in cirrhotic patients [25]. 
Kim et al. [26] reported that cirrhotic patients, who 
underwent TIPS before major surgery, had a lower rate 
of short-term mortality than previously published reports 
on patients who did not undergo TIPS.
The MELD score is a risk stratification model 
for cirrhotic patients that recently exhibited high 
predictive utility for perioperative mortality [27]. The 
MELD score is characterized by its objective measures 
and weights of its variables, which can potentially 
increase its precision for the prediction of 30-day 
post-operative mortality in cirrhotic patients [28]. In 
the current work, we demonstrated that non-survivors 
were more likely to have a MELD score between 9 and 
16 than survivors. In concordance with our findings, 
Hemida et al. [29] showed that the MELD score had 
high sensitivity (100%) and moderate specificity (64%) 
for the prediction of death in cirrhotic cases submitted 
to non-hepatic procedures. Another retrospective 
study demonstrated that MELD score was associated 
with 90-day mortality following emergency surgery in 
patients with cirrhosis [30].
To the best of our knowledge, no or very 
limited data in the literature have addressed the issue 
of measuring PVP in Child’s A cirrhosis undergoing 
elective surgery, and so we think that this may be a 
novel field of research. Even in the present study, 
we found a cutoff value for PVP readings that could 
increase post-operative mortality and seem to have 
acceptable sensitivity and specificity. Expecting patients 
who are at a high risk of mortality will encourage us 
to be very cautious regarding these patients and their 
post-operative care and so may improve the outcome in 
such patient category through their strict post-operative 
management and from this point, come the suggested 
importance and novelty of this research.
Despite this, we claim that this work has some 
limitations. The work was a single-center experience 
that may impact the generalizability of our results. 
Furthermore, more studies on a larger number of 
patients and unified types of surgical procedures are 
required for objective validation of results.
Conclusion
I.O measurement of PVP is a feasible and 
simple procedure that can predict the short-term 
mortality in Child’s A cirrhotic patients undergoing 
elective surgery. PVP exhibited an acceptable diagnostic 
utility for mortality and was an independent predictor of 
30-day mortality. Nevertheless, further studies are still 
warranted to underline our findings due to the currently 
limited number of published literature.
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